Conditions:  BRCA1 Mutation;  POLD1 Gene Mutation;  CDKN2A Mutation;  BRCA2 Mutation;  POLE Gene Mutation;  APC Gene Mutation;  ATM Gene Mutation;  MLH1 Gene Mutation;  BARD1 Gene Mutation;  MSH2 Gene Mutation;  BRIP1 Gene Mutation;  MSH6 Gene Mutation;  CHEK2 Gene Mutation;  PMS2 Gene Mutation;  PALB2 Gene Mutation;  EPCAM Gene Mutation;  RAD51C Gene Mutation;  BMPR1A Gene Mutation;  RAD51D Gene Mutation;  SMAD4;  PTEN Gene Mutation;  GREM1
Interventions:  Other: Intervention Arm At-risk Relative/ARR Contacts;  Behavioral: Multidimensional Impact of Cancer Risk Assessment questionnaire;  Behavioral: Satisfaction with Decision Scale;  Behavioral: Cancer Prevention Behaviors uptake and intentions;  Behavioral: Genetics Knowledge;  Behavioral: Modified version of the Acceptability E-scale
Sponsor:  Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**
Interventions:  Other: Intervention Arm At-risk Relative/ARR Contacts;  Behavioral: Multidimensional Impact of Cancer Risk Assessment questionnaire;  Behavioral: Satisfaction with Decision Scale;  Behavioral: Cancer Prevention Behaviors uptake and intentions;  Behavioral: Genetics Knowledge;  Behavioral: Modified version of the Acceptability E-scale
Sponsor:  Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
